Prof. Oo said, "Heart valve replacement therapy presents several post-operative challenges for patients, especially the need for blood thinners and the related risk of bleeding and thrombotic events.

AUSTIN, Texas--(BUSINESS WIRE)--Privately held On-X® Life Technologies Inc. (On-X LTI), whose mechanical heart valves have been implanted in more than 150,000 patients in over 90 countries, announced ...

The Bokros Carbomedics On-X Bileaflet Valve was developed by Dr. Jack Bokros PhD, a nuclear engineer in collaboration with Dr. Vincent Gott, a pioneering cardiac surgeon who spent thirty-five years ...

Medical device company Artivion (NYSE:AORT) reported Q3 CY2025 results , with sales up 18.4% year on year to $113.4 million. The company’s full-year revenue guidance of $442 million at the midpoint ...